Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Lori Goldstein

Email
Center AffiliationsMolecular Therapeutics

Publications (101) (print view)

no pagination
Cianfrocca M, Goldstein LJ. Operable breast cancer. Current treatment options in oncology. 2001 Apr;2(2):157-67.
Fowble B, Hanlon A, Freedman G, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Torosian M, Goldstein L. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 2000 Jul;47(4):883-94.
Stadtmauer EA, Goldstein LJ, Glick JH. High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer - Reply. New England Journal of Medicine. 2000 Aug 10;343(6):440-1.
Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, Brodsky I, Martino S, Lazarus HM, Erban JK, Sickles C, Glick JH. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. New England Journal of Medicine. 2000 Apr 13;342(15):1069-76.
Fowble B, Hanlon A, Freedman G, Patchefsky A, Kessler H, Nicolaou N, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Postmenopausal hormone replacement therapy: Effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. Journal of Clinical Oncology. 1999 Jun;17(6):1680-8.
Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. International Journal of Radiation Oncology Biology Physics. 1999 Jul 15;44(5):1005-15.
Dexter DW, Reddy RK, Geles KG, Bansal S, Myint MA, Rogakto A, Leighton JC, Goldstein LJ. Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma. Clinical Cancer Research. 1998 Jun;4(6):1533-42.
Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation. International Journal of Radiation Oncology Biology Physics. 1998 Aug;42(1):105-15.
Freedman GM, Fowble BL, Hanlon AL, Myint MA, Hoffman JP, Sigurdson ER, Eisenberg BL, Goldstein LJ, Fein DA. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. International Journal of Radiation Oncology Biology Physics. 1998 Jun;41(3):599-605.
Freedman GM, Fowble BL, Hanlon AL, Fein DA, Hoffman JP, Sigurdson ER, Goldstein LJ. Postmastectomy radiation and adjuvant systemic therapy: outcomes in high-risk women with stage II-III breast cancer and assessment of clinical, pathologic, and treatment-related factors influencing local-regional control. Breast Journal. 1997 Nov;3(6):337-44.
Sparano JA, Neuberg D, Glick JH, Robert NJ, Goldstein LJ, Sledge GW, Wood W. Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: An eastern cooperative oncology group study. Journal of Clinical Oncology. 1997 May;15(5):1880-4.
Fowble B, Fein DA, Hanlon AL, Eisenberg BL, Hoffman JP, Sigurdson ER, Daly MB, Goldstein LJ. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. International Journal of Radiation Oncology Biology Physics. 1996 Jul;35(4):669-77.
Goldstein LJ. MDR1 gene expression in solid tumours. European Journal of Cancer. 1996 Jun;32A(6):1039-50.
Crilley P, Goldstein LJ. Peripheral-Blood Stem-Cell Transplant in Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):238-49.
Sledge GW, Robert N, Sparano JA, Cogleigh M, Goldstein LJ, Neuberg D, Rowinsky E, Baughman C, McCaskillstevens W. Eastern-Cooperative-Oncology-Group Studies of Paclitaxel and Doxorubicin in Advanced Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):105-8.
Kruh GD, Goldstein LJ. Doxorubicin and multidrug resistance. Current Opinion in Oncology. 1993 Jan;5(6):1029-34.
Lerman C, Daly M, Sands C, Balshem A, Lustbader E, Heggan T, Goldstein L, James J, Engstrom P. Mammography Adherence and Psychological Distress among Women at Risk for Breast-Cancer. Journal of the National Cancer Institute. 1993 Jul 07;85(13):1074-80.
Sauter ER, Eisenberg BL, Hoffman JP, Ottery FD, Boraas MC, Goldstein LJ, Solin LJ. Postmastectomy Morbidity after Combination Preoperative Irradiation and Chemotherapy for Locally Advanced Breast-Cancer. World Journal of Surgery. 1993 Mar;17(2):237-42.
Sauter ER, Eisenberg BL, Hoffman JP, Ottery FD, Boraas MC, Goldstein LJ, Solin LJ, Kinne DW. Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer. World Journal of Surgery. 1993 Jan;17(2):237-42.
Goldstein LJ, Pastan I, Gottesman MM. Multidrug Resistance in Human Cancer. Critical Reviews in Oncology/Hematology. 1992 May;12(3):243-53.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

Lori Goldstein Sparkline Graph

Graph Interactions

Co-Authors:

Similar Investigators:


Keywords (MeSH):


Last updated on Friday, December 06, 2019